Prescription guides / Nonhormonal
Veozah vs gabapentin for hot flashes: approval, monitoring and cost questions
At a glance
Veozah (fezolinetant) is approved for moderate to severe hot flashes due to menopause. Gabapentin is used off-label for hot flashes and is supported as an option by The Menopause Society’s 2023 nonhormone statement. Compare liver monitoring, kidney-related prescribing considerations, sedation and the full treatment budget with your clinician; these are not interchangeable prescriptions. Sources: Veozah source, Gabapentin source, Nonhormone source.
| Decision | Veozah | Gabapentin |
|---|---|---|
| Menopause hot-flash use | FDA-approved indication | Off-label; evidence-supported option |
| Estrogen included? | No | No |
| Key review issue | Required liver testing and contraindications | Renal function, sedation and interacting sedatives |
| Budget unit | Medicine plus required tests and visits | Exact formulation, prescribed schedule and follow-up |
Sources: Veozah source, Gabapentin source, Nonhormone source.
What off-label means for this decision
The gabapentin label reviewed here covers postherpetic neuralgia and adjunctive seizure treatment, not menopausal hot flashes. The Menopause Society’s 2023 statement nevertheless recommends gabapentin among evidence-supported nonhormone options. Those facts can both be true. Ask the prescriber why it is being considered, what response to track and how follow-up will work. This comparison does not copy a pain or seizure dosing schedule into a menopause prescription. Sources: Gabapentin source, Nonhormone source.
Veozah requires a monitoring budget
The Veozah label requires liver tests before treatment, monthly for the first three months, and at months six and nine after starting. Ask about the price and location of those tests as well as the medicine. It carries a liver-injury boxed warning and specific contraindications and interactions. A low pharmacy copay does not mean the complete treatment has no additional cost. Sources: Veozah source.
Gabapentin raises a different set of practical questions
The label includes renal dose-adjustment considerations, dizziness, drowsiness and driving impairment. It also warns about respiratory depression with other central nervous system depressants, including opioids, or underlying respiratory impairment. Bring a full list of prescription and nonprescription medicines to the clinician. Choosing a nonhormonal option does not eliminate the need for interaction and safety review. Sources: Gabapentin source.
Do not turn sleepiness into a self-prescribing plan
If symptoms mainly disturb sleep, explain that to the prescriber. Do not treat gabapentin’s potential drowsiness as proof that it is the best option or change its timing or dose without instructions. If you already take it for another condition, that existing prescription needs review before adding or repurposing treatment for menopause symptoms. Ask how any eventual reduction or discontinuation should be managed. Sources: Gabapentin source.
Compare what will actually be dispensed
For gabapentin, record the exact dosage form, strength, daily prescribed quantity and days of supply; do not assume all formulations use the same schedule. For Veozah, include the medicine quote and required testing. Ask the insurer about the exact prescribed use, prior authorization and covered pharmacy. No current matched price survey was obtained, so this page does not claim a guaranteed generic saving or coverage outcome.
Evidence supports a conversation, not a winner
The cited guidance supports both medicines as nonhormone options but does not make this page a head-to-head trial. Ask what matters for your situation: symptoms, other medicines, kidney or liver history, daily functioning and access to monitoring. A treatment that is affordable but cannot be safely followed is not a complete solution. Arrange a clear follow-up point rather than repeatedly changing treatment because of a coupon or an online testimonial. Sources: Nonhormone source.
Questions before filling the prescription
Is gabapentin FDA-approved for menopausal hot flashes?
No. This is an off-label use, even though professional guidance supports it as an option.
Does either medicine contain estrogen?
No. They are different nonhormonal medicines.
Can I skip liver tests if Veozah is working?
No. Follow its required monitoring plan and prescriber instructions.
Does gabapentin need the same liver-test schedule?
The specific Veozah schedule is not a gabapentin instruction. Gabapentin requires its own clinical review, including renal function when relevant.
Can I use leftover gabapentin for night sweats?
Do not repurpose an old prescription. Ask the clinician to review the symptoms, medicine and schedule.
Which is cheaper overall?
Obtain matched prescription quotes and include required tests and visits. No universal total is established here.
Prepare your next discussion
Use the menopause tools to organize questions about symptoms, options and budget.
Explore the menopause calculatorsRelated decisions
This is a source-based comparison, not an independent clinical review. Read the complete current product information with your clinician. Quoted supply calculations do not authorize a dose change.